+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Long-term clinical impact of sentinel lymph node biopsy in breast cancer and cutaneous melanoma

Long-term clinical impact of sentinel lymph node biopsy in breast cancer and cutaneous melanoma

Quarterly Journal of Nuclear Medicine and Molecular Imaging 58(2): 95-104

Sentinel lymph node biopsy (SLNB) is based on the hypothesis that the sentinel lymph node (SLN) reflects the lymph-node status and a negative SLN might allow complete axillary lymph node dissection (ALND) to be avoided. Past and current sentinel lymph node clinical trials for breast carcinoma and melanoma address the prognostic and therapeutic utility of SLN dissection (SLND). This technique has already become a standard of care for breast cancer patients and select patients with melanoma. However, it is still important to discuss current techniques and some controversies. This article reviews these issues as well as current guidelines for treatment and management of patients with various findings on SLNB.

(PDF emailed within 1 workday: $29.90)

Accession: 054162449

Download citation: RISBibTeXText

PMID: 24835286

Related references

The long-term prognostic impact of sentinel lymph node biopsy in patients with primary cutaneous melanoma: a prospective study with 10-year follow-up. Annals of Surgical Treatment and Research 95(5): 286-296, 2018

A 10-year analysis of primary cutaneous malignant melanoma with sentinel lymph node biopsy and long-term follow-up. International Journal of Dermatology 52(2): 220-230, 2013

Sentinel node biopsy and selective lymph node clearance--impact on regional control and survival in breast cancer and melanoma. European Journal of Nuclear Medicine and Molecular Imaging 32(6): 631-634, 2005

Long-term morbidity of patients with early breast cancer after sentinel lymph node biopsy compared to axillary lymph node dissection. Journal of Surgical Oncology 93(2): 109-119, 2006

Lymph node status and survival in cutaneous malignant melanoma--sentinel lymph node biopsy impact. European Journal of Surgical Oncology 29(7): 611-618, 2003

Sentinel lymph node biopsy to stage patients with cutaneous melanoma at the National Cancer Institute of Naples. Results from 240 sentinel node biopsies. Tumori 88(3): S12-S13, 2002

Long-term Outcome of Patients Managed With Sentinel Lymph Node Biopsy Alone for Node-Negative Invasive Breast Cancer. Archives of Surgery 147(11): 1047-1052, 2012

A Longitudinal Comparison of Arm Morbidity in Stage III Breast Cancer Patients Treated with Sentinel Lymph Node Biopsy, Sentinel Lymph Node Biopsy Followed by Completion Lymph Node Dissection, or Axillary Lymph Node Dissection. Breast Diseases: A Year Book Quarterly 22(1): 68-70, 2011

A longitudinal comparison of arm morbidity in stage I-II breast cancer patients treated with sentinel lymph node biopsy, sentinel lymph node biopsy followed by completion lymph node dissection, or axillary lymph node dissection. Annals of Surgical Oncology 17(9): 2384-2394, 2010

Repeat sentinel lymph node biopsy in patients with ipsilateral recurrent breast cancer after breast-conserving therapy and negative sentinel lymph node biopsy: a prospective study. Minerva Chirurgica 71(2): 73-79, 2015

Follow-up of excision of cutaneous melanoma: sentinel node biopsy, lymph node ultrasound or clinical surveillance alone?. Annales de Dermatologie et de Venereologie 132(12 Pt 1): 941-944, 2006

Cutaneous melanoma: therapeutic lymph node and elective lymph node dissections, lymphatic mapping, and sentinel lymph node biopsy. Dermatologic Therapy 18(6): 397-406, 2005

The number of removed axillary sentinel lymph nodes and its impact on the diagnostic accuracy of sentinel lymph node biopsy in breast cancer. Rozhledy V Chirurgii 92(1): 21-26, 2013

Short-term morbidity associated with sentinel lymph node biopsy in cutaneous malignant melanoma. Australasian Journal of Dermatology 51(1): 13-17, 2010

Sentinel lymph node biopsy for breast cancer: will variations in technique influence long-term outcome?. Annals of Surgical Oncology 12(9): 686-688, 2005